MAB8537
Anti-Herpes Virus 6 Antibody, A & B, gp 60/110
Chemicon®, from mouse
Synonym(s):
HHV6
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Recommended Products
biological source
mouse
Quality Level
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
immunofluorescence: suitable
immunoprecipitation (IP): suitable
western blot: suitable
isotype
IgG2b
shipped in
wet ice
Specificity
Specific for the gp 60/110 envelope glycoprotein of HHV6.
CELLULAR LOCALIZATION:
Cytoplasmic and membrane
STRAIN RECOGNITION:
Types A & B
CELLULAR LOCALIZATION:
Cytoplasmic and membrane
STRAIN RECOGNITION:
Types A & B
Immunogen
Epitope: A & B, gp 60/110
Application
Detect Herpes Virus 6 using this Anti-Herpes Virus 6 Antibody, A & B, gp 60/110 validated for use in IF, IP & WB.
Western Blot 1:10 - 1:50
Immunofluorescence 1:10-1:50
Immunoprecipitation 1:10-1:50
Optimal working dilutions must be determined by end user.
Immunofluorescence 1:10-1:50
Immunoprecipitation 1:10-1:50
Optimal working dilutions must be determined by end user.
Physical form
Format: Purified
Purified immunoglobulin. Liquid in 0.01 M phosphate buffered saline (PBS) pH 7.2, containing 0.1% sodium azide.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Not finding the right product?
Try our Product Selector Tool.
Storage Class Code
10 - Combustible liquids
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications.
J O Virtanen, M Farkkila, J Multanen, L Uotila, A J Jaaskelainen, A Vaheri, M Koskiniemi
Journal of Neurovirology null
Kageaki Kuribayashi et al.
Internal medicine (Tokyo, Japan), 45(7), 475-478 (2006-05-09)
A 31-year-old man referred to our hospital for treatment of his chronic myeloid leukemia (CML) in the first chronic phase by bone marrow transplantation. We pretreated him with cyclophosphamide and total body irradiation and bone marrow transplantation (BMT) was carried
Purification of infectious human herpesvirus 6A virions and association of host cell proteins.
Hammarstedt, M; Ahlqvist, J; Jacobson, S; Garoff, H; Fogdell-Hahn, A
Virology Journal null
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service